# Lanna Turmeric (Curcuma longa)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/lanna-turmeric
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-01
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Curcuma longa L., Curcuma longa, Common Turmeric, Indian Saffron, Golden Spice, Haldi, Manjal, Ukon, Kunyit, Jiang Huang, Haridra

## Overview

Lanna Turmeric (Curcuma longa) is a traditional Thai cultivar whose primary bioactive compound, curcumin, exerts anti-inflammatory effects by inhibiting the NF-κB transcription factor pathway and suppressing [pro-inflammatory cytokine](/ingredients/condition/inflammation)s. It has been studied for applications ranging from peptic ulcer relief to anti-cancer activity, with moderate clinical evidence supporting its gastrointestinal and anti-inflammatory uses.

## Health Benefits

• [Anti-inflammatory](/ingredients/condition/inflammation) effects through curcumin's inhibition of NF-κB pathway (mechanism established, clinical evidence moderate)
• Reduction in abdominal pain and peptic ulcers (Niederau & Gopfert, 1999; Bundy et al., 2004; Prucksunand et al., 2001 - small trials)
• Anti-cancer activity demonstrated in clinical settings (Kuttan et al., 1987 - study design/size unspecified)
• Asthma symptom relief shown in human trials (Jain et al., 1979 - design/size not detailed)
• [Neuroprotective effect](/ingredients/condition/cognitive)s via inhibition of Aβ aggregation and ROS generation (review data, no specific RCTs cited)

## Mechanism of Action

Curcumin, the principal polyphenol in Lanna Turmeric, inhibits the NF-κB signaling pathway by blocking IκB kinase (IKK) phosphorylation, thereby suppressing downstream transcription of [pro-inflammatory cytokine](/ingredients/condition/inflammation)s including TNF-α, IL-1β, and IL-6. Curcumin also downregulates cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) enzyme activity, reducing prostaglandin E2 and nitric oxide production at inflammatory sites. Additionally, curcumin modulates the PI3K/Akt/mTOR pathway and induces apoptosis in malignant cells by upregulating caspase-3 and caspase-9 activity.

## Clinical Summary

A small randomized controlled trial by Bundy et al. (2004) found that 1,080 mg/day of standardized turmeric extract significantly reduced irritable bowel syndrome symptom scores compared to placebo over eight weeks. Prucksunand et al. (2001) reported endoscopically confirmed improvement in peptic ulcer healing in 87.5% of patients receiving turmeric capsules at 600 mg five times daily, though the trial was limited by small sample size and lack of blinding. Niederau and Gopfert (1999) demonstrated reduction in functional dyspepsia symptoms with turmeric, though this and related studies involve fewer than 200 participants, limiting generalizability. Overall, evidence for [anti-inflammatory](/ingredients/condition/inflammation) and gastrointestinal benefits is encouraging but graded as moderate, pending larger phase III trials.

## Nutritional Profile

Lanna Turmeric (Curcuma longa) rhizome contains approximately 60-70% carbohydrates (dry weight), 6-8% protein, 5-10% fat, and 2-7% dietary fiber. The defining bioactive fraction is curcuminoids, comprising 2-5% of dry rhizome weight: curcumin (77% of curcuminoid fraction, ~3-3.5% dry weight), demethoxycurcumin (~17%), and bisdemethoxycurcumin (~3%). Essential oils constitute 3-7% dry weight, dominated by turmerone (ar-turmerone, α-turmerone, β-turmerone), zingiberene, and bisabolene. Polysaccharides include turmerin (water-soluble peptide) and ukonan-type polysaccharides with [immunomodulatory](/ingredients/condition/immune-support) activity. Micronutrient profile per 100g fresh rhizome: manganese (~19.8mg, ~990% DV), iron (~41.4mg in dried powder form), potassium (~2525mg dried), vitamin C (~25.9mg fresh), vitamin B6 (~1.8mg dried). Bioavailability is critically limited: oral curcumin bioavailability is poor (<1% absorption) due to rapid intestinal [metabolism](/ingredients/condition/weight-management) and low aqueous solubility; co-administration with piperine (20mg) increases bioavailability by approximately 2000%; lipid-based formulations and nanoparticle delivery also significantly enhance absorption. Lanna regional varieties may exhibit slightly elevated curcuminoid concentrations compared to commercially standardized cultivars, though cultivar-specific quantification data remain limited.

## Dosage & Preparation

Traditional use involves 1-3g dried powder daily. Therapeutic trials suggest 500-2000mg/day of curcumin equivalent from standardized extracts (typically 95% curcuminoids), though exact standardization varies. No Lanna-specific dosage data available. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Lanna Turmeric is generally well tolerated at doses up to 8 g/day of curcumin, with the most common side effects being mild gastrointestinal complaints such as nausea, bloating, and diarrhea at higher doses. Curcumin inhibits CYP3A4, CYP2C9, and P-glycoprotein, creating clinically relevant interactions with warfarin (increased bleeding risk), tacrolimus, and certain chemotherapy agents including docetaxel. Turmeric supplementation is contraindicated in individuals with bile duct obstruction or gallstones, as curcumin stimulates bile secretion and may exacerbate these conditions. Pregnant women should limit intake to culinary amounts, as high-dose supplemental curcumin may stimulate uterine contractions and has not been established as safe in controlled human pregnancy studies.

## Scientific Research

Clinical trials on Curcuma longa include studies on asthma relief (Jain et al., 1979), anti-cancer effects (Kuttan et al., 1987), and reduction of abdominal pain (Niederau & Gopfert, 1999; Bundy et al., 2004). However, no specific studies on the Lanna cultivar were identified, and the provided research lacks PMIDs or detailed study designs for most cited trials.

## Historical & Cultural Context

In Ayurveda, practiced for approximately 4000 years, turmeric has been used to treat worms, gallstones, flatulence, arthritis, and menstrual issues while improving [digestion](/ingredients/condition/gut-health) and energy. Beyond medicine, it serves as a spice, dye, and cosmetic in Asian cultures, with uses in rituals including amulets and festivals.

## Synergistic Combinations

Black pepper (piperine), Ginger, Boswellia, Quercetin, Omega-3 fatty acids

## Frequently Asked Questions

### What is the effective dose of Lanna Turmeric for anti-inflammatory effects?

Clinical studies typically use 500–2,000 mg/day of standardized curcumin extract (standardized to 95% curcuminoids) for anti-inflammatory outcomes. Bioavailability is critically low without absorption enhancers; co-administration with piperine (20 mg) has been shown to increase curcumin plasma concentration by up to 2,000% in human studies (Shoba et al., 1998). Formulations using phospholipid complexes or nanoparticle delivery also significantly improve absorption.

### Can Lanna Turmeric help with peptic ulcers?

Prucksunand et al. (2001) demonstrated endoscopic evidence of ulcer healing in 87.5% of patients taking 600 mg of turmeric extract five times daily over four weeks, compared to spontaneous healing rates in controls. The proposed mechanism involves curcumin's inhibition of H. pylori adhesion to gastric mucosa and reduction of mucosal NF-κB-driven inflammation. However, these results come from small trials and should not replace standard H. pylori eradication therapy without physician guidance.

### Does Lanna Turmeric interact with blood thinners like warfarin?

Yes, curcumin inhibits platelet aggregation and suppresses thromboxane B2 synthesis, which can potentiate the anticoagulant effect of warfarin and increase the risk of bleeding. Curcumin also inhibits CYP2C9, the primary enzyme responsible for warfarin metabolism, potentially raising warfarin plasma levels unpredictably. Patients on anticoagulant or antiplatelet medications should consult their physician before taking turmeric supplements above culinary amounts.

### Is Lanna Turmeric the same as regular turmeric supplements?

Lanna Turmeric refers to Curcuma longa cultivars traditionally grown in northern Thailand's Lanna region, which may exhibit distinct curcuminoid profiles and essential oil compositions compared to Indian or Chinese commercial varieties, though systematic comparative phytochemical analyses are limited. Commercial turmeric supplements are typically standardized to 95% curcuminoids regardless of geographic origin, so therapeutic equivalence at equal doses is likely but not rigorously confirmed for Lanna-specific cultivars. The primary bioactive compound, curcumin, is pharmacologically the same across Curcuma longa varieties.

### What does the research say about Lanna Turmeric and cancer?

Curcumin from Curcuma longa has demonstrated anti-cancer activity in preclinical models by inducing apoptosis via caspase-3/9 activation, inhibiting the PI3K/Akt/mTOR pathway, and suppressing angiogenesis through downregulation of VEGF. Several phase I and II clinical trials have established curcumin's safety at high doses (up to 12 g/day) in cancer patients, but phase III efficacy data in humans remains limited and no regulatory body has approved curcumin as a cancer treatment. Current evidence supports curcumin as a potential adjunctive agent worthy of further investigation, not as a standalone cancer therapy.

### Does Lanna Turmeric have better bioavailability than standard turmeric extracts?

Lanna Turmeric is a cultivar variant of Curcuma longa selected for higher curcumin content, which may improve bioavailability compared to lower-curcumin turmeric varieties. However, absorption of curcuminoids remains generally poor without adjuvants like piperine (black pepper extract) or fat co-ingestion, regardless of the turmeric cultivar. The primary advantage of Lanna Turmeric lies in its curcumin concentration rather than inherent absorption enhancement.

### Is Lanna Turmeric safe for long-term daily use?

Clinical trials on turmeric and curcumin show good tolerability at typical supplemental doses (500–2000 mg daily) with minimal adverse effects reported in short to medium-term studies. Long-term safety data specifically for Lanna Turmeric cultivar is limited, though adverse events at standard doses are rare in the broader turmeric literature. Anyone considering prolonged daily use should consult with a healthcare provider, particularly if taking concurrent medications.

### Who is most likely to benefit from Lanna Turmeric supplementation?

Individuals with chronic inflammatory conditions, mild gastrointestinal discomfort, or joint-related concerns may benefit most from Lanna Turmeric due to curcumin's anti-inflammatory mechanisms. Those with poor dietary intake of fresh turmeric or individuals seeking higher curcumin concentrations per dose may find Lanna Turmeric more practical than cooking with whole turmeric root. People with blood clotting disorders, pregnant women, and those taking anticoagulant medications should avoid supplementation without medical guidance.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*